PHARMA & DEMAND RESPONSE
Significantly reduce carbon impact
Manufacturing medicinal and pharmaceutical products can be particularly energy intensive. Processing, cleanrooms, lighting, heating and ventilation all add to a plant’s carbon footprint as well as having a significant financial impact.
Due to the critical nature of producing large batches of life saving medicines and products, pharma companies typically have back-up energy assets in place, to ensure secure and reliable power for manufacturing. Some of these assets – standby generators, batteries and Uninterruptible Power Supplies (UPS), are ideal sources to provide Security of Supply for the national power system when it’s needed, via Demand Response services.
In doing so, pharma companies become energy providers to the grid and enable more renewable electricity to be consumed, all while benefiting from a new revenue stream for the business. This additional revenue source has the added benefit of helping depreciating assets to pay for themselves.
Examples of how our customers participate
Metals & Mining
Food & Beverages
Fully Managed Demand Response
Our highly experienced engineers will help leverage and optimise your site’s existing assets for Demand Response participation. We have a proven track record of creating bespoke solutions for mission critical businesses and can deploy across multiple sites if required. Expect end-to-end expert support every step of the way and zero impact to your business continuity.
How it works
Our specialist team will expertly plan, implement, roll-out and support your participation in the electricity market.
VIOTAS onboards and tests your suitable sites.
Our expert team will onboard and test your sites with minimal interruption.
Join the energy market and play your part in supporting renewable energy and offsetting carbon emissions.
When the grid requires Demand or Frequency Response support, VIOTAS enables your sites to participate.
Get paid for supporting the grid in times of need.
Monthly payments with no CAPEX or OPEX investments.